Guanfacine | Health Canada Patents | Expiry | Expiration | Dates | PharmaCompass.com

Please Wait

Applying Filters...

Grow Your Pharma Business Digitally

Find Suppliers : API/FDF
- Search Our Integrated Database
Services
Excipients
Drugs in Dev.
News
Blog
Market Place
Login

Guanfacine
Health Canada Patents

EUROAPI, the leading small molecules API player, provides both API sales & CDMO services.

Contact Supplier

SPI Pharma has been solving formulation challenges using superior functional materials.

Contact Supplier

Interquim comes from an international group of 50 companies active in the pharma, hospital, diagnostics, fine chemicals & feed sectors.

Contact Supplier

Cohance Lifesciences, offers full range of CDMO services for small molecule APIs, intermediates, ADCs, Pellets and Formulations.

Contact Supplier

FAMAR CDMO- From early development to commercial manufacturing.

Contact Supplier

Polfa Tarchomin is a leading Polish pharmaceutical company with 200 year tradition in manufacture and sale of pharmaceutical products.

Contact Supplier

Guanfacine

ACCESS ALL DATA, CHEMISTRY

ACCESS ALL DATA
Browse all information
CHEMISTRY
Discover Molecule Insights

ACTIVE PHARMA INGREDIENTS

14 API Suppliers, 10 USDMF, 1 JDMF, 2 EU WC, 10 NDC API, 6 Listed Suppliers, $ API Reference Price

14 API Suppliers
10 USDMF
1 JDMF
2 EU WC
10 NDC API
6 Listed Suppliers
$ API Reference Price

INTERMEDIATES

1 Intermediate Suppliers

1 Intermediate Suppliers

FINISHED DOSAGE FORMULATIONS

115 FDF Dossiers, 77 FDA Orange Book, 18 Europe, 12 Canada, 4 Australia, 4 Listed Dossiers

115 FDF Dossiers
77 FDA Orange Book
18 Europe
12 Canada
4 Australia
4 Listed Dossiers

RELATED EXCIPIENT COMPANIES

5 Evonik, 4 SPI Pharma, 2 Seqens, 1 DKSH, 5 Faran Shimi Pharmaceutical, 6 Boai NKY Pharmaceuticals Ltd, 3 Gangwal Healthcare, 2 Nanjing Well Pharmaceutical, 1 ACG Worldwide, 3 Actylis, 1 Aeon Procare, 2 Alcedo Pharmachem, 6 Anhui Sunhere Pharmaceutical Excipients Co.,Ltd, 33 BASF, 15 Corel Pharma Chem, 5 DFE Pharma, 1 Finar, 9 Gangwal Chemicals, 13 Ideal Cures Pvt Ltd, 2 Ingredion Pharma Solutions, 36 Kerry, 4 Kima Chemical, 6 Lonza Capsugel, 15 Microlex e.U, 2 Nomisma Healthcare, 3 Novo Excipients, 3 Pharmatrans-Sanaq, 5 Pluviaendo, 2 Prachin Chemical, 1 Qianhao Chemical (Hebei) Co., Ltd, 1 Qualicaps, 17 Roquette, 7 Seppic, 4 Shanghai Shenmei Pharmaceutical Technology Co., Ltd, 10 Sigachi Industries, 3 The Dow Chemical Company, 1 Ulanqab Kema New Material, 1 Valens Pharmachem, 2 Vasa Pharmachem

EXCIPIENTS BY APPLICATIONS

67 Fillers, Diluents & Binders, 66 Coating Systems & Additives, 41 Controlled & Modified Release, 29 Direct Compression, 28 Granulation, 22 Solubilizers, 20 Thickeners and Stabilizers, 20 Disintegrants & Superdisintegrants, 17 Lubricants & Glidants, 13 Film Formers & Plasticizers, 13 Taste Masking, 11 Co-Processed Excipients, 11 Topical, 9 Chewable & Orodispersible Aids, 6 Parenteral, 5 Empty Capsules, 5 Emulsifying Agents, 4 Vegetarian Capsules, 4 API Stability Enhancers, 2 Coloring Agents, 2 Rheology Modifiers, 1 Surfactant & Foaming Agents

67 Fillers, Diluents & Binders
66 Coating Systems & Additives
41 Controlled & Modified Release
29 Direct Compression
28 Granulation
22 Solubilizers
20 Thickeners and Stabilizers
20 Disintegrants & Superdisintegrants
17 Lubricants & Glidants
13 Film Formers & Plasticizers
13 Taste Masking
11 Co-Processed Excipients
11 Topical
9 Chewable & Orodispersible Aids
6 Parenteral
5 Empty Capsules
5 Emulsifying Agents
4 Vegetarian Capsules
4 API Stability Enhancers
2 Coloring Agents
2 Rheology Modifiers
1 Surfactant & Foaming Agents

DIGITAL CONTENT

23 NEWS #PharmaBuzz

23 NEWS #PharmaBuzz

GLOBAL SALES INFORMATION

2 US Medicaid Prescriptions, 16 Finished Drug Prices, 10 Annual Reports

2 US Medicaid Prescriptions
16 Finished Drug Prices
10 Annual Reports

MARKET PLACE

6 APIs, 1 FDF Dossiers

6 APIs
1 FDF Dossiers

PATENTS & EXCLUSIVITIES

4 Health Canada Patents

4 Health Canada Patents

REF. STANDARDS & IMPURITIES

1 USP, 2 Others

1 USP
2 Others

$ API Ref.Price (USD/KG) : 4,937 Xls

Filters

Reset all filters

Filters

FILTER :

filter Company Reset all filters

4 All

01 4Gowling WLG (Canada) LLP

filter Patent Reset all filters

4 All

01 42432178

filter Product Reset all filters

4 All

01 4Guanfacine Hydrochloride

filter Dosage Reset all filters

4 All

01 4Extended Release Tablet

filter Exp Date Reset all filters

4 All

01 42021-12-20

Product Main Page

01

Gowling WLG (Canada) LLP

Guanfacine

PharmScience R&D

Not Confirmed

Gowling WLG (Canada) LLP

Canada

PharmScience R&D

Not Confirmed

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

Patent Expiration Date : 2021-12-20

Date Granted : 2010-04-20

Brand Name : INTUNIV XR

Patent Number : 2432178

Filing Date : 2001-12-20

Strength per Unit : 1 mg

Dosage Form : Extended Release Tablet

Human Or VET : Human

Route of Administration : Oral

Patent Expiration Date : 2021-12-20

Date Granted : 2010-04-20

Portfolio PDF

Product Web Link

Digital Content

Corporate PDF

02

Gowling WLG (Canada) LLP

Guanfacine

PharmScience R&D

Not Confirmed

Gowling WLG (Canada) LLP

Canada

PharmScience R&D

Not Confirmed

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

Patent Expiration Date : 2021-12-20

Date Granted : 2010-04-20

Brand Name : INTUNIV XR

Patent Number : 2432178

Filing Date : 2001-12-20

Strength per Unit : 2 mg

Dosage Form : Extended Release Tablet

Human Or VET : Human

Route of Administration : Oral

Patent Expiration Date : 2021-12-20

Date Granted : 2010-04-20

Portfolio PDF

Product Web Link

Digital Content

Corporate PDF

03

Gowling WLG (Canada) LLP

Guanfacine

PharmScience R&D

Not Confirmed

Gowling WLG (Canada) LLP

Canada

PharmScience R&D

Not Confirmed

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

Patent Expiration Date : 2021-12-20

Date Granted : 2010-04-02

Brand Name : INTUNIV XR

Patent Number : 2432178

Filing Date : 2001-12-20

Strength per Unit : 3 mg

Dosage Form : Extended Release Tablet

Human Or VET : Human

Route of Administration : Oral

Patent Expiration Date : 2021-12-20

Date Granted : 2010-04-02

Portfolio PDF

Product Web Link

Digital Content

Corporate PDF

04

Gowling WLG (Canada) LLP

Guanfacine

PharmScience R&D

Not Confirmed

Gowling WLG (Canada) LLP

Canada

PharmScience R&D

Not Confirmed

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

Patent Expiration Date : 2021-12-20

Date Granted : 2010-04-20

Brand Name : INTUNIV XR

Patent Number : 2432178

Filing Date : 2001-12-20

Strength per Unit : 4 mg

Dosage Form : Extended Release Tablet

Human Or VET : Human

Route of Administration : Oral

Patent Expiration Date : 2021-12-20

Date Granted : 2010-04-20

Portfolio PDF

Product Web Link

Digital Content

Corporate PDF

Contact us
to update this info

Privacy policy
Terms and conditions
Disclaimers
ASK US!